SSA
AEON.WS

Schonfeld Strategic Advisors’s AEON Biopharma Inc AEON.WS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,865
Closed -$7K – 3151
2022
Q1 		$7K Hold
22,865
– – ﹤0.01% 2448
2021
Q4 		$12K Buy
+22,865
New +$12.6K ﹤0.01% 2022

Other funds holding AEON.WS

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

Schonfeld Strategic Advisors's AEON.WS Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of AEON Biopharma Inc (AEON.WS) in Q1 2024, closing a stake of 15,000 shares — an estimated $1.31K sold.

Schonfeld Strategic Advisors first reported a position in AEON.WS in Q2 2022 and held it in 7 quarters. The position peaked at $3K in Q2 2022. 30 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining AEON Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 15,000 AEON Biopharma Inc shares in Q1 2024, an estimated $1.31K.
  • Schonfeld Strategic Advisors first reported a position in AEON Biopharma Inc in Q2 2022 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's AEON Biopharma Inc position peaked at $3K in Q2 2022.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.